There have been tremendous recent advances in the pharmacotherapy, dose regimens, and combinations used to treat cancer and for the treatment or prevention of the spread of disease. As a direct result of these advances, there are an increasing number of cancer survivors, although research dealing with chemotherapy-induced pain is still in its early years. Written for pain management specialists, oncologists, pharmacologists, students, and primary care practitioners, Chemotherapy-Induced Neuropathic Pain provides insight into the important area of chemotherapy-induced neuropathic pain. It reviews the basic and clinical research into the normal physiology of pain transmission pathways, neuropathic pain pathology, the chemotherapeutic drug mechanisms of action and adverse effects, chemotherapy-induced neuropathy, and drug discovery efforts for treatment. The contributors comprise an impressive list of clinical and basic science experts in the fields of pain mechanisms and pain management. Included are clinical directors of pain clinics and clinical research facilities, directors of large academic pain research laboratories, analgesic drug developers, and presidents of the International Association for the Study of Pain (IASP), Association of Chronic Pain Patients (ACPP), and the British Pain Society (BPS). Through them, the book provides the reader with an exceptional opportunity to acquire a fundamental understanding of the basic concepts related to this topic.
Format:
CONTRIBUTORS: Robert B. Raffa, Richard Langford, Frank Porreca, Ronald J. Tallarida, Joseph V. Pergolizzi Jr.
EAN: 9780367381028
COUNTRY: United Kingdom
PAGES:
WEIGHT: 435 g
HEIGHT: 234 cm
PUBLISHED BY: Taylor & Francis Ltd
DATE PUBLISHED: 2019-09-19
CITY:
GENRE: HEALTH & FITNESS / Pain Management, MEDICAL / General, MEDICAL / Neurology, MEDICAL / Oncology / General
WIDTH: 156 cm
SPINE:
Book Themes:
Chemotherapy, Pain and pain management
Robert B. Raffa, Ph.D. is Professor and Chair within the Department of Pharmaceutical Sciences at Temple University School of Pharmacy, in Philadelphia, Pennsylvania.Ronald J. Tallarida, Ph.D. is Professor of Pharmacology at Temple University School of Medicine in Philadelphia, Pennsylvania.Frank Porreca, Ph.D. is Professor of Pharmacology and Anesthesiology at Temple University in Philadelphia, Pennsylvania.Joseph V. Pergolizzi, Jr., M.D. is Adjunct Assistant Professor at Johns Hopkins University School of Medicine in Baltimore, Maryland.
